Helicobacter pylori is a Gram-negative bacterium that is present in the stomach of at least half of the world's human population. In this niche, it persists for decades unless treated, and consistently induces gastric inflammation. Infection with this organism is a significant risk factor for the development of peptic ulcer disease, gastric carcinoma, and gastric lymphoproliferative diseases. The long-term objective of this project is to elucidate pathogenic mechanisms whereby H. pylori causes human disease, and to develop effective means for prevention and treatment of infection. In an effort to accomplish these goals, this proposal focuses investigation upon an important virulence determinant of H. pylori: the vacuolating cytotoxin. Although nearly all isolates contain a gene (vacA) encoding the cytotoxin, only about 50% produce vacuolating cytotoxin activity in vitro. Infection with cytotoxin-producing (tox+) strains is associated with an increased risk for peptic ulcer disease; moreover, administration of the purified cytotoxin intragastrically to mice induces gastric ulceration. In preliminary studies, it has been demonstrated that vacA structural gene sequences in tox+ strains differ substantially from those in tox- strains. In addition, it has been demonstrated that levels of vacA transcription are increased in tox+ strains compared to tox- strains. Finally, it has been demonstrated that the cytotoxin binds to epithelial cells and is internalized prior to inducing cytoplasmic vacuolation. The hypotheses of this proposal are (i) that the tox+ phenotype is dependent upon the presence of specific vacA structural gene domains which are absent from vacA homologs in tox- strains, (ii) that vacA transcription is regulated differently in tox+ and tox- strains, and (iii) that specific vacA domains or subunits are required for binding of the toxin to cells, intracellular trafficking, and induction of vacuolation.
The specific aims are: to determine the basis for differences among H. pylori strains in levels of vacuolating cytotoxin activity, and to identify antigenic and functionally important domains of the cytotoxin. To accomplish the first objective, a series of chimeric vacA genes, derived in part from a tox+ strain and in part from a tox- strain, will be constructed and analyzed. In addition, a trans- acting vacA regulatory element will be sought. To accomplish the second objective, a series of recombinant vacA peptides will be synthesized, and polyclonal antisera prepared for these peptides. The antisera will be tested for the capacity to block binding and intracellular trafficking of the cytotoxin, as well as vacuole formation. In addition, the products of a series of vacA deletion mutants will be tested for functional activity. Finally, the regions of vacA that elicit an antibody response in humans will be determined by testing human sera for reactivity with the panel of recombinant vacA peptides. Understanding the structure and regulation of the vacuolating cytotoxin may aid in the development of strategies to prevent and treat H. pylori-associated gastroduodenal illnesses.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Raghunathan, Krishnan; Foegeding, Nora J; Campbell, Anne M et al. (2018) Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA. Infect Immun 86:
Beckett, Amber C; Loh, John T; Chopra, Abha et al. (2018) Helicobacter pylori genetic diversification in the Mongolian gerbil model. PeerJ 6:e4803
Loh, John T; Beckett, Amber C; Scholz, Matthew B et al. (2018) High-Salt Conditions Alter Transcription of Helicobacter pylori Genes Encoding Outer Membrane Proteins. Infect Immun 86:
Noto, Jennifer M; Chopra, Abha; Loh, John T et al. (2018) Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments. Gut 67:1793-1804
Butt, Julia; Blot, William J; Teras, Lauren R et al. (2018) Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 27:1186-1194
Kyburz, A; Urban, S; Altobelli, A et al. (2017) Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy. Clin Exp Allergy 47:1331-1341
Feichtinger, René G; Neureiter, Daniel; Skaria, Tom et al. (2017) Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis. Oxid Med Cell Longev 2017:1320241
McClain, Mark S; Beckett, Amber C; Cover, Timothy L (2017) Helicobacter pylori Vacuolating Toxin and Gastric Cancer. Toxins (Basel) 9:
Bullock, Kennady K; Shaffer, Carrie L; Brooks, Andrew W et al. (2017) Genetic signatures for Helicobacter pylori strains of West African origin. PLoS One 12:e0188804
González-Rivera, Christian; Campbell, Anne M; Rutherford, Stacey A et al. (2016) A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain. Infect Immun 84:2662-70

Showing the most recent 10 out of 79 publications